By inhibiting the STING-NLRP3 signalling pathway, liver fibrosis can be attenuated and potential mechanisms involving oxidative stress and metabolic reprogramming can be revealed [93]. This evidence concerns the gene NLRP3 and Hepatic fibrosis.